| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |